METHOD FOR PREPARING HER2 NANOBODY AND CONJUGATE, AND USE THEREOF

ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE

ENGINEERED SARS-COV-2 ANTIBODIES WITH INCREASED NEUTRALIZATION BREADTH

CDCP1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES

IMMUNOGLOBULIN VARIABLE DOMAINS

PRECISION ACTIVATED POLYPEPTIDES

LIPID NANOPARTICLES AND METHODS OF MANUFACTURE AND USE THEREOF

CD117-TARGETING NANOPARTICLES FOR USE IN DRUG DELIVERY

POLYPEPTIDE CONSTRUCTS SELECTIVELY BINDING TO CLDN6 AND CD3

ANTI-KLRG1 ANTIBODIES

Antibodies Binding to ILT4

VHH POLYPEPTIDES THAT BIND TO MESOTHELIN, COMPOSITIONS AND METHODS OF USE THEREOF

Nanobody targeting IL-23A and application thereof

VHH ANTIBODIES AND USES THEREOF

NOVEL ANTI-CD3EPSILON ANTIBODIES

NOVEL SIRP NANOBODIES

CD8b-BINDING POLYPEPTIDES

ANTI-CCR8 ANTIBODIES

TREATMENT AND PREVENTION OF CANCER USING VISTA ANTIGEN-BINDING MOLECULES

COMPOSITION FOR PROPHYLAXIS OR TREATMENT OF IL-8 RELATED DISEASES

METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION

ANTIBODY AND CHIMERIC ANTIGEN RECEPTORS TARGETING GCC AND METHODS OF USE THEREOF

TRANSGENIC NON-HUMAN ANIMALS PRODUCING MODIFIED HEAVY CHAIN-ONLY ANTIBODIES

CD3 BINDING ANTIBODIES

CHIMERIC ANTIGEN RECEPTORS AGAINST MULTIPLE HLA-G ISOFORMS

ANTIGEN BINDING MOLECULES TO CD3 AND CD19

METHODS, SYSTEMS, AND KITS FOR TREATMENT OF INFLAMMATORY DISEASES TARGETING TL1A

NANOBODY, POLYPEPTIDE CONTAINING SAID NANOBODY AND USE THEREOF

BISPECIFIC ANTIBODY AND APPLICATION THEREOF

BINDING MEMBERS WITH ALTERED DIVERSITY SCAFFOLD DOMAINS

ANTI-NOTCH3 ANTIBODY

ANTI-ETEC ADHESIN PROTEIN ANTIBODIES AND METHODS OF USE

HUMAN BROADLY NEUTRALIZING ANTIBODIES AGAINST BETACORONAVIRUSES

MATERIALS AND METHODS FOR EVALUATION OF ANTIGEN PRESENTATION MACHINERY COMPONENTS AND USES THEREOF

CD47 BINDING AGENTS

COMPOSITIONS AND METHODS COMPRISING EPITOPES AND POLYPEPTIDES

Antigen Binding Molecules Targeting Interleukine-4 Receptor Subunit Alpha (IL-4Ra)

TREATMENT OF HEADACHE DISORDERS AND/OR PSYCHIATRIC SYMPTOMS USING ANTI-CGRP ANTIBODIES, AND COMPOSITIONS AND METHODS RELATED THERETO

ANTI-TSHR ANTIBODIES AND USES THEREOF

T CELL RECRUITING POLYPEPTIDES BASED ON CD3 REACTIVITY

ANTI-NECTIN-4 ANTIBODY AND USE THEREOF

COMMON LIGHT CHAIN MOUSE

TARGETING ART1 FOR CANCER IMMUNOTHERAPY

NANOBODY AND NANOBODY-DRUG CONJUGATE TARGETING CD73, METHOD FOR PREPARING SAME, AND USE THEREOF

MUSCLE-TARGETING COMPLEXES AND USES THEREOF

ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE

POLYPEPTIDE MODIFICATION METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS

HUMANIZED ANTI-CD28 ANTIBODY AND BISPECIFIC ANTIBODY THEREOF WITH ANTI-CD40 ANTIBODY

ANTI-CD40 ANTIBODY, ANTI-PD-L1×CD40 BISPECIFIC ANTIBODY, AND USE THEREOF

COMPOSITIONS AND METHODS RELATED TO RECEPTOR PAIRINGS

MONOCLONAL ANTIBODY AGAINST TFPI AND USE THEREOF

C-KIT BINDING PROTEINS, CHIMERIC ANTIGEN RECEPTORS, AND USES THEREOF

ANTIBODIES AND ANTIBODY FRAGMENTS THAT BIND IGE

SERINE PROTEASE INHIBITOR KAZAL (SPIK) COMPOSITIONS AND METHODS

ANTI-CD84 ANTIBODIES AND USES THEREOF

DUAL SPECIFIC ANTIBODIES

METHODS FOR TREATING DIABETIC KIDNEY DISEASE AND GLOMERULAR DISEASE

BINDING DOMAIN MOLECULES ON CELL SURFACES

ANTI CD40 ANTIBODY, ANTIGEN BINDING FRAGMENT AND MEDICAL USE THEREOF

COMPOSITIONS AND METHODS RELATED TO RECEPTOR PAIRINGS

HUMAN ANTI-HUMAN PLA2R ANTIBODY STANDARD SUBSTANCE AND USE THEREOF

CD3 BINDING ANTIBODIES

CLDN18.2-TARGETING ANTIBODY, BISPECIFIC ANTIBODY AND USE THEREOF

ANTIBODY AND USE THEREOF

IL10RB BINDING MOLECULES AND ENCODING NUCLEIC ACIDS

MULTI-DOMAIN MOLECULES

HUMANIZED ANTI-CD8 ANTIBODIES AND USES THEREOF

CLAUDIN18.2 HUMANIZED ANTIBODY AND APPLICATION THEREOF

5T4 BINDING AGENTS AND USES THEREOF

ANTI-TIGIT ANTIBODIES AND METHODS OF USE

ANTI-ALLERGEN ANTIBODIES AND USES THEREOF

NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 AND USES THEREOF

HUMANIZED NON-OPIOID COMPOSITION AND THERAPIES FOR PAIN MANAGEMENT

RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTOR 1 (ROR1)-SPECIFIC VHH ANTIBODIES AND MULTISPECIFIC ANTIBODIES THEREOF AS IMMUNE CELL ENGAGERS

V.kappa.4-1-IGLC Polypeptide and Use Thereof

ANTI-BLOOD DENDRITIC CELL ANTIGEN 2 ANTIBODIES AND USES THEREOF

ANTIBODIES TO AMYLOID BETA

NEUTRALIZING MONOCLONAL ANTIBODIES TO BK VIRUS

ANTI-MUC17 NANOBODY AND USE THEREOF

ANTI-CD16A ANTIBODY AND APPLICATION THEREOF

Anti-B7-H4 Antibodies and Immunoconjugates

PRECISION ACTIVATED POLYPEPTIDES

METHODS OF TREATING AUTOIMMUNE AND ALLOIMMUNE DISORDERS

ROR1-SPECIFIC ANTIGEN BINDING MOLECULES

MONOCLONAL ANTIBODY AGAINST HLA-G1, HLA-G4 AND HLA-G5 ISOFORMS AND USE THEREOF

ANTI-CANCER COMBINATION THERAPIES COMPRISING CTLA-4 AND PD-1 BLOCKING AGENTS

ANTI-HUMAN CD45RC BINDING DOMAINS AND USES THEREOF

ANTIBODIES THAT BIND GLUCOSAMINIDASE AND USES THEREOF

ANTI-PD-L1 ANTIBODY AND USE THEREOF

ANTIBODY SPECIFICALLY BINDING TO CD47 AND ANTIGEN-BINDING FRAGMENT THEREOF

Albumin-Binding Polypeptides and Uses Thereof

MUSCLE-TARGETING COMPLEXES AND USES THEREOF

RECOMBINANT POLYPEPTIDES COMPRISING SINGLE-DOMAIN ANTIBODIES TARGETING HERV-K SUBTYPE HML-2

SPECIFIC BINDING MOLECULES

NOVEL ANTI-SIRPA ANTIBODIES

CLDN18.2 ANTIBODY AND USE THEREOF

ANTI-ABETA ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF AND APPLICATION THEREOF

TAU BINDING MOLECULES

ROR1-SPECIFIC VARIANT ANTIGEN BINDING MOLECULES

Treatment and Prophylaxis of Amyloidosis

Chimeric Antigen Receptor Molecule for Specifically Recognizing Baff-R and Application of Chimeric Antigen Receptor Molecule

ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF

ANTI-IGF-1 RECEPTOR HUMANIZED ANTIBODY

NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE

CYTOTOXICITY-INDUCING THERAPEUTIC AGENT

ANTIBODY OR ANTIGEN-BINDING FRAGMENT CAPABLE OF IDENTIFYING ANG-2, AND BISPECIFIC ANTIBODY FOR SIMULTANEOUSLY IDENTIFYING VEGF AND ANG-2

METHODS OF TREATING INFLAMMATORY DISEASES WITH COMBINATION OF TL1A INHIBITORS AND IL23 INHIBITORS

Compositions for Redirecting Immunoglobulins to Immune Cells

COMPOSITIONS AND METHODS FOR TREATING CANCER

ANTI-CD39 NANOBODY AND USES THEREOF

ANTI-DECTIN-1 ANTIBODIES AND METHODS OF USE THEREOF

HUMANIZED ANTIBODIES WITH INCREASED STABILITY

METHODS AND AGENTS FOR THE TREATMENT OF OCULAR DISEASE

Antibodies to Botulinum Neurotoxins

MONOCLONAL ANTIBODIES AND BISPECIFIC ANTIBODY AGAINST C-MET

Compounds

NON-IMMUNOGENIC SINGLE DOMAIN ANTIBODIES

HUMANIZED ANTI-NUCLEAR ANTIBODIES FOR TARGETING NECROSIS IN CANCER THERAPY

Human Epidermal Growth Factor Receptor Binding Molecule and Use Thereof

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING MAGE-A

ANTI-ADENOSINE RECEPTOR (A2aR) ANTIBODIES AND THE USE THEREOF

ANTI-ETEC ADHESIN PROTEIN ANTIBODIES AND METHODS OF USE

ANTI-CD94 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-INTERLEUKIN-11 ANTIBODY AND USE THEREOF

BISPECIFIC ANTIBODIES TO HIV-1 ENV AND THEIR USE

HUMANIZED ANTI-CD8 ANTIBODIES AND USES THEREOF

ANTI-IL-4RA ANTIBODIES AND USES THEREOF

ANTIBODY BINDING TO CLOSTRIDIUM DIFFICILE

ANTIBODY COMPOSITIONS FOR DISRUPTING BIOFILMS

IMMUNE CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND BISPECIFIC ANTIBODIES AND USES THEREOF

NOVEL BISPECIFIC ANTIGEN BINDING MOLECULES CAPABLE OF SPECIFIC BINDING TO CD40 AND TO FAP

GROWTH HORMONE RECEPTOR TARGETING POLYPEPTIDES

COMPOSITIONS AND METHODS RELATED TO IL27 RECEPTOR BINDING

Integrin Alpha10 Antibody

Anti-SIRPa Antibodies and Methods of Use Thereof

MODIFIED-IgG ANTIBODIES THAT BIND TRANSFORMING GROWTH FACTOR-BETA1 WITH HIGH AFFINITY, AVIDITY AND SPECIFICITY

IL27RAlpha BINDING MOLECULES AND METHODS OF USE

MONOCLONAL ANTIBODY AGAINST HLA-G MOLECULES AND USE THEREOF

COMPOSITIONS AND METHODS FOR DETECTING dsRNA

FELINE ANTIBODY LIBRARY

ANTIBODY LIBRARIES

ANTI-MIGIS-alpha ANTIBODIES AND METHODS OF USE THEREOF

ANTI-IL-17A ANTIBODIES AND THEIR USE IN TREATING AUTOIMMUNE AND INFLAMMATORY DISORDERS

BISPECIFIC ANTIBODY AND APPLICATION THEREOF

RECOMBINANT ANTIBODY OF ANTI-HUMAN CARDIAC TROPONIN I

MODIFIED PROTEINS AND PEPTIDES

BOREALIN TARGETING POLYPEPTIDES FOR DETECTION AND TREATMENT OF CANCER

TREATMENT AND PREVENTION OF CANCER USING HER3 ANTIGEN-BINDING MOLECULES

HUMANIZED ANTI-CLAUDIN-1 ANTIBODIES AND USES THEREOF

ANTIBODIES TO FELINE MCDONOUGH SARCOMA (FMS)-LIKE TYROSINE KINASE 3 RECEPTOR LIGAND (FLT3L) AND USES THEREOF FOR TREATING AUTOIMMUNE AND INFLAMMATORY DISEASES

PTK7 BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME

ADAM9-Binding Molecules, and Methods of Use Thereof

BISPECIFIC ANTIBODY AGAINST ALPHA-SYN/IGF1R AND USE THEREOF

ANTI-DLL3 ANTIBODY AND PREPARATION METHOD THEREFOR, DRUG CONJUGATE AND APPLICATION THEREOF

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38

DUAL SPECIFIC ANTIBODIES

MYELOPROLIFERATIVE CONDITIONS

HIGH AFFINITY HUMAN AND MONKEY SPECIFIC TFR-1 VNARS

METHOD OF TREATING IGA NEPHROPATHY BY ADMINISTERING ALTERED ANTIBODIES WHICH BIND HUMAN A PROLIFERATION-INDUCING LIGAND (APRIL) PROTEIN

ANTI-MESOTHELIN ANTIBODIES AND USES THEREOF

HUMANIZED ANTIBODY CAPABLE OF BINDING TO HEG1 PROTEIN

HUMANIZED ANTI-CCR7 RECEPTOR ANTIBODIES

ANTI-CDH6 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES THEREOF

PHARMACEUTICAL COMPOSITION OR DRUG KIT FOR ALLEVIATING OR TREATING FIBROTIC DISEASES, AND USE THEREOF

PERTUZUMAB VARIANTS AND EVALUATION THEREOF

ANTI P2X7 RECEPTOR ANTIBODIES AND FRAGMENTS THEREOF

METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING A DISEASE OR DISORDER ASSOCIATED WITH ABNORMAL LEVEL AND/OR ACTIVITY OF THE IFP35 FAMILY OF PROTEINS

Methods for Producing Anti-TNF Antibody Compositions

STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF

ANTIBODIES TARGETING HIV ESCAPE MUTANTS

ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS

ANTIBODIES FOR TREATING ALPHA-SYNUCLEINOPATHIES

METHOD OF PREPARING PH-DEPENDENT ANTIBODIES

METHODS FOR DETECTING OR TREATING INFLUENZA INFECTIONS

METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING A DISEASE OR DISORDER ASSOCIATED WITH ABNORMAL LEVEL AND/OR ACTIVITY OF THE IFP35 FAMILY OF PROTEINS

ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY ANTIBODIES

COMPOSITION CONTAINING MONOCLONAL ANTIBODY

MONOCLONAL ANTIBODIES SPECIFIC FOR SARS-COV-2 RBD

ANTI-CD-25 ANTIBODY

MONOCLONAL ANTIBODY AGAINST HLA-G1, -G2, -G5 AND HLA-G6 ISOFORMS AND USE THEREOF

MONOCLONAL ANTIBODIES AGAINST HUMAN TIM-3

MODIFIED PROTEIN OR POLYPEPTIDE

ANTIBODY BINDING TO FCRN FOR TREATING AUTOIMMUNE DISEASES

BINDING MOLECULES

POLYPEPTIDES FOR DETECTION AND TREATMENT OF CORONAVIRUS INFECTION

IMMUNOGLOBULINS AND USES THEREOF

CELL-BINDING PROTEINS AND METHODS OF USE

Methods for Producing Anti-TNF Antibody Compositions

ANTIBODIES AND METHODS OF USE

ANTI-CANINE PD-L1 ANTIBODIES

TREATMENT AND DIAGNOSIS OF DISEASES ASSOCIATED TO PATHOGENIC FIBROSIS

OPTIMIZED NUCLEIC ACID ANTIBODY CONSTRUCTS

MULTISPECIFIC BINDING AGENTS AGAINST PD-L1 AND CD137 IN COMBINATION THERAPY

PREVENTION OF POSTERIOR CAPSULAR OPACIFICATION (PCO) WITH INTEGRIN AVB8 BLOCKING ANTIBODY

SARS-CORONAVIRUS 2 NEUTRALIZING ANTIBODY

ANTI-PD-1 ANTIBODY AND USE THEREOF

METHODS AND COMPOSITIONS RELATED TO MCL-1 AND BIM HETERODIMER ANTIBODIES

ANTIBODY MOLECULES TO DENGUE VIRUS AND USES THEREOF

HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE

BIOPHARMACEUTICAL COMPOSITIONS AND RELATED METHODS

MULTISPECIFIC BINDING AGENTS AGAINST PD-L1 AND CD137 IN COMBINATION WITH ANTI PD-1 ANTIBODIES FOR TREATING CANCERS

METHODS AND COMPOSITIONS FOR INCREASING N-ACETYLGLUCOSAMINIDASE ACTIVITY IN THE CNS

INCENP TARGETING POLYPEPTIDES FOR DETECTION AND TREATMENT OF CANCER

SYNTHETIC HUMANIZED LLAMA NANOBODY LIBRARY AND USE THEREOF TO IDENTIFY SARS-COV-2 NEUTRALIZING ANTIBODIES

ANTI-ETEC ADHESIN PROTEIN ANTIBODIES AND METHODS OF USE

POLYPEPTIDE MODIFICATION METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS

ANTI-NGLY-1 ANTIBODIES AND METHODS OF USE

HUMANIZED AND AFFINITY MATURED ANTIBODIES TO FcRH5 AND METHODS OF USE

Multivalent and Multispecific DR5-Binding Fusion Proteins

IL23R BINDING MOLECULES AND METHODS OF USE

NOVEL DYSFUNCTIONAL P2X7 BINDERS

ANTI-TRYPTASE ANTIBODIES, COMPOSITIONS THEREOF, AND USES THEREOF

ANTI-TROP2 SINGLE-DOMAIN ANTIBODY AND USE THEREOF

METHODS AND COMPOSITIONS FOR STIMULATING IMMUNE ACTIVITY

GENERATION AND CHARACTERIZATION OF NOVEL TIM-4 BINDING AGENTS

ANTI-DLL3 ANTIBODIES AND USES THEREOF

BINDING AGENTS TARGETING TROP2-EXPRESSING TUMOR CELLS

MULTISPECIFIC ANTIBODIES AND USES THEREOF

ANTI-PD-L1 AND IL-2 CYTOKINES

ANTI-CD3 HUMANIZED ANTIBODY

Antigen Binding Molecules Targeting SARS-CoV-2

Anti-CCR8 Antibodies and Uses Thereof

ANTIBODIES COMPRISING A POLYPEPTIDE INSERTED IN FRAMEWORK 3 REGION

Antibodies Having Humanized Framework Regions

MULTISPECIFIC ANTIBODIES FOR IMMUNO-ONCOLOGY

ANTIBODY MOLECULES TO PG-L1 AND METHODS OF TREATING CANCER AND INFECTIOUS DISEASES

MULTISPECIFIC BINDING AGENTS AGAINST CD40 AND CD137 IN COMBINATION THERAPY FOR CANCER

BINDING AGENTS TARGETING TROP2-EXPRESSING TUMOR CELLS

ANTI-PD-L1 NANOBODY AND USE THEREOF

NORA INHIBITORS AND METHODS OF USE

Binding agents targeting TROP2-expressing tumor cells

BINDING AGENTS TARGETING TROP2-EXPRESSING TUMOR CELLS

ANTIBODIES AGAINST PD-L1

ANTI-CD3 ANTIBODIES

ANTI-CD3 ANTIBODY AND USE THEREOF

ANTI-CD25 ANTIBODY AGENTS

ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE

ANTIBODIES RECOGNIZING TAU

HUMANIZED GPC3 ANTIBODY AND APPLICATION THEREOF

ANTIGEN BINDING MOLECULES WITH INCREASED FC RECEPTOR BINDING AFFINITY AND EFFECTOR FUNCTION

Anti-SIRPα antibodies and methods of use thereof

ANTIBODIES TO SARS-COV-2

ANTI-NR10 ANTIBODY AND USE THEREOF

IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS

ANTIBODY SPECIFIC FOR ANTI-BCL-6 ANTIBODY AND METHODS OF USE

ANTIBODIES TO AMYLOID BETA

INTERLEUKIN 11 RECEPTOR ALPHA SUBUNIT (IL11RA) NEUTRALIZING ANTIBODIES AND USES THEREOF

Treatment of Cardiovascular Disease with TREM-1 Antigen Binding Proteins

DUAL SPECIFIC ANTIBODIES

ANTI-uPAR ANTIBODIES AND USES THEREOF

NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE

ANTI-CEACAM5/6 ANTIGEN-BINDING MOLECULES AND METHODS OF TREATMENT THEREOF

BISPECIFIC SINGLE DOMAIN ANTIBODY TO PD-L1 AND CD47 AND USE THEREOF

Binding molecules

ANTI-UNC5C ANTIBODIES

Compositions and methods related to IL27 receptor binding

GP130 Binding Molecules and Methods of Use

ANTI-NGF ANTIBODIES AND USES THEREOF

HUMAN ANTIBODY TARGETING COVID-19 VIRUS

MESOTHELIN BINDING MOLECULE AND APPLICATION THEREOF

IL-1 receptor accessory protein-inhibiting antibodies and antigen-binding fragments thereof

SPECIFIC BINDING MOLECULES

ANTI-LY6G6D ANTIBODIES AND METHODS OF USE

ANTI-DENGUE VIRUS ANTIBODIES HAVING CROSS-REACTIVITY TO ZIKA VIRUS AND METHODS OF USE

AMINO ACID SEQUENCES THAT MODULATE THE INTERACTION BETWEEN CELLS OF THE IMMUNE SYSTEM

Properdin binding protein and use thereof

ANTI-CGRP COMPOSITIONS AND USE THEREOF

ANTIGEN-BINDING PROTEIN TARGETING PNEUMOLYSIN AND USE THEREOF

IL12RB1-BINDING MOLECULES AND METHODS OF USE

VISTA ANTIGEN-BINDING MOLECULES

BIFUNCTIONAL MOLECULE BINDING TO HUMAN TGFß AND PD-L1, AND USE THEREOF

NS1-BINDING PROTEIN

Method for Producing Antibody-Lysosomal Enzyme Fusion Protein

COMMON LIGHT CHAIN MOUSE

PD-L1-SPECIFIC ANTIBODIES AND METHODS OF USING THE SAME

ANTI-MASP-2 ANTIBODY AND USE THEREOF

BISPECIFIC SINGLE DOMAIN ANTIBODY TO PD-L1 AND CD47 AND USE THEREOF

ANTIGEN-BINDING MOLECULES WITH IMPROVED CYTOSOL-PENETRATING ACTIVITY

MULTI-DOMAIN FUSION PROTEIN AND USE THEREOF

PREPARATION OF SIGLEC-15 BINDING PROTEIN AND USE THEREOF

ANTIBODIES AND ASSAYS FOR CCL14

Antigen binding proteins specifically binding MAGE-A

CX3CR1-BINDING COMPOUNDS, METHODS AND USES THEREOF

ANTI-TIGIT ANTIBODIES AND METHODS OF USE

Modified-IgG antibodies that bind transforming growth factor-β1 with high affinity, avidity and specificity

HUMAN MONOCLONAL ANTIBODIES AGAINST PNEUMOCOCCAL ANTIGENS

ANTIBODIES TARGETING THE SPIKE PROTEIN OF CORONAVIRUSES

HUMANIZED ANTIBODY AGAINST TNFR2 AND USE THEREOF

IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING T CELL RECEPTOR

ANTIBODIES BINDING TO LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR SUBFAMILY B MEMBER 2 (LILRB2) AND USES THEREOF

TNF ALPHA AND NGF ANTIBODIES FOR VETERINARY USE

Bispecific Antibody to A-Syn/IGF1R and Use Thereof

ANTIBODY THAT BINDS TO VEGF AND IL-1BETA AND METHODS OF USE

ANTI-VLA-4 ANTIBODIES

AUTOIMMUNE SUPPRESSOR AND APPLICATION THEREOF

ANTI-PD-1 SINGLE-DOMAIN ANTIBODY

ANTIBODY VARIABLE DOMAINS AND ANTIBODIES HAVING DECREASED IMMUNOGENICITY

HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODIES TO CD47

ANTI-HUMAN CD22 MONOCLONAL ANTIBODIES AND USE THEREOF